{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:33:19Z","timestamp":1777073599345,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.dmpk.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T23:27:07Z","timestamp":1522970827000},"page":"270-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4"],"prefix":"10.1016","volume":"33","author":[{"given":"Yuri","family":"Ishiguro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Furugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2018.03.004_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1684\/epd.2014.0720","article-title":"Concept of epilepsy surgery and presurgical evaluation","volume":"17","author":"Rathore","year":"2015","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.dmpk.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.seizure.2015.02.020","article-title":"The impact of seizures on pregnancy and delivery","volume":"28","author":"Sveberg","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.dmpk.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1528-1167.2008.01926.x","article-title":"Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?","volume":"49","author":"Pennell","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.dmpk.2018.03.004_bib4","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dmpk.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.dmpk.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(99)00398-1","article-title":"Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line","volume":"195","author":"Utoguchi","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dmpk.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(01)00912-8","article-title":"Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo)","volume":"417","author":"Ushigome","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.placenta.2015.03.010","article-title":"Molecular and functional characterization of choline transporter in the human trophoblastic cell line JEG-3 cells","volume":"36","author":"Yara","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.dmpk.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1023\/A:1014242931475","article-title":"Proton gradient-dependent transport of valproic acid in human placental\u00a0brush-border membrane vesicles","volume":"19","author":"Nakamura","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmpk.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family-structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol Aspect Med"},{"issue":"4","key":"10.1016\/j.dmpk.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1074\/jbc.M114.581892","article-title":"Functional characterization of 5-oxoproline transport via SLC16A1\/MCT1","volume":"290","author":"Sasaki","year":"2015","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.dmpk.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbrc.2017.10.025","article-title":"Identification of a selective inhibitor of human monocarboxylate transporter 4","volume":"495","author":"Futagi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.dmpk.2018.03.004_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2008.07.034","article-title":"Expression and function of TETRAN, a new type of membrane transporter","volume":"374","author":"Ushijima","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.dmpk.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1124\/dmd.105.005264","article-title":"Functional characterization of human monocarboxylate transporter 6 (SLC16A5)","volume":"33","author":"Murakami","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cell.2017.06.011","article-title":"Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms","volume":"170","author":"Rusu","year":"2017","journal-title":"Cell"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436717305505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436717305505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:54:02Z","timestamp":1761162842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436717305505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1347436717305505"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.03.004","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}